Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study

AIM: To assess the potential gain in the number of life‐years free of a (recurrent) cardiovascular disease (CVD) event with optimal cardiovascular risk management (CVRM) and initiation of glucose‐lowering agents with proven cardiovascular benefit in people with type 2 diabetes (T2D). MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Østergaard, Helena Bleken, Humphreys, Valerie, Hengeveld, Ellen Margo, Honoré, Julie Broe, Mach, François, Visseren, Frank L. J., Westerink, Jan, Yadav, Gourav, Mosenzon, Ofri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092227/
https://www.ncbi.nlm.nih.gov/pubmed/36199242
http://dx.doi.org/10.1111/dom.14887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092227/
https://www.ncbi.nlm.nih.gov/pubmed/36199242
http://dx.doi.org/10.1111/dom.14887

Ejemplares similares